Exclusive: Georgiamune is selling a preclinical cancer drug to Italy’s Menarini in a deal worth up to $1.1B.
endpoints.newsExclusive: Georgiamune sells solid tumor drug to Italy's Menarini for up to $1.1BMenarini Group has agreed to scoop up an oral small molecule from Georgiamune for $45 million in upfront and near-term payments.
0 reposts0 likes